Jose Tinajero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California, San FranciscoPharmD, 2019
Publications & Presentations
PubMed
- 5 citationsBRAF V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes.Mina Nikanjam, Jose Tinajero, Donald A. Barkauskas, Razelle Kurzrock
Molecular Cancer Therapeutics. 2021-03-15 - 1 citationsTyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia.Tamer Othman, Paul Koller, Hoda Pourhassan, Vaibhav Agrawal, Dat Ngo
British Journal of Haematology. 2024-08-01 - 1 citationsCladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In Relapsed and Refractory Acute Myeloid Leukemia Patients.Jose Tinajero, Dat Ngo, Amandeep Salhotra, Paul Koller
Acta Haematologica. 2023-01-01
Office
601 S Wolfe St
Baltimore, MD 21231
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
